485 Repurposing disulfiram for the treatment of Merkel cell carcinoma
Natasha T. Hill(National Institutes of Health), Isaac Brownell(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Tara Gelb(National Institutes of Health), Matthew D. Hall(National Institutes of Health), Dan Urban(National Center for Advancing Translational Sciences), Tyler Kellenberger(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Serena Vilasi(National Institutes of Health), A. Lin(National Institute of Arthritis and Musculoskeletal and Skin Diseases)
Cited by 0
Related Papers
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
|International Journal of Radiation Oncology*Biology*Physics|2013|380
KDM5 histone demethylases repress immune response via suppression of STING
|PLoS Biology|2018|166
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
|Molecular Therapy|2020|127
Anti–PD-L1 Treatment Induced Central Diabetes Insipidus
|The Journal of Clinical Endocrinology & Metabolism|2017|102
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
|Frontiers in Pharmacology|2021|95